| 2012 Events |
Location |
Date |
Title |
| 2012 CABA Annual Conference: Meeting the Challenges Through Innovation |
Cambridge, MA |
April 7, 2012 |
Solution to "Tough-to-Drug" Targets: Integrated Discovery Engine of Macrocycles, DNA-Programmed Chemistry, Affinity-Based Selections & Next Generation Sequencing |
| ACS National Medicinal Chemistry Symposium |
Tucson, AZ |
May 20-24, 2012 |
Moving in new circles - Exploiting macrocycles for drug discovery |
| 13th Annual Drug Discovery & Development Leaders Summit 2012 |
Zurich, Switzerland |
June 11-13, 2012 |
Discovery and Preclinical Advancement of a Novel Class of Small Molecule IL17:IL17R Antagonists |
| International Cytokine Society: IL-17 and Related Cytokines: Basic Biology and Clinical Applications |
Dublin, Ireland |
June 18-21, 2012 |
Synthetic Macrocycle Antagonists of IL17 |
| Harvard Office of Technology Development, 5th Annual Life Science Networking Reception: Celebrating (with) Harvard Startups |
Boston, MA |
June 19, 2012 |
DNA-Programmed Chemistry in an Integrated Macrocycle Affinity-Based Selection Discovery Engine for "Tough-to-Drug" Targets |
[ ]
|
